75 employees
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
2020
$40M
from 3 investors over 3 rounds
Tune Therapeutics raised $40M on December 2, 2021
Investors: Mission BioCapital, Emerson Collective and Saisei Ventures